⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
WGRX News
Wellgistics Health, Inc. Common Stock
Wellgistics Health Inc. unterzeichnet Absichtserklärung über 105.000.000 $ zur Prüfung einer möglichen Übernahme von Neuritek Therapeutics, Inc., einem Pionierunternehmen für innovative Therapien bei neurologischen und psychiatrischen Erkrankungen
accessnewswire.com
WGRX
Wellgistics Health Inc.签署1.05亿美元意向书，拟评估收购Neuritek Therapeutics, Inc.的可行性，后者致力于开发神经系统及精神疾病的创新疗法
accessnewswire.com
WGRX
Wellgistics Health Inc., Nörolojik ve Psikiyatrik Bozukluklar İçin Yenilikçi Tedavilere Öncülük Eden Neuritek Therapeutics, Inc.'i Satın Almak Üzere 105 Milyon Dolarlık Niyet Mektubu İmzaladı
accessnewswire.com
WGRX
Wellgistics Health Inc.签署1.05亿美元意向书，拟评估收购Neuritek Therapeutics, Inc.的可行性，后者致力于开发神经系统及精神疾病的创新疗法
accessnewswire.com
WGRX
Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share
accessnewswire.com
WGRX
Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction
accessnewswire.com
WGRX
Form 8-K
sec.gov
WGRX
Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities
accessnewswire.com
WGRX
Form 8-K
sec.gov
WGRX
Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM)
accessnewswire.com
WGRX